BNP Paribas Issuance (P1KFL6) 뉴스

IDAI................................https://stockcharts.com/h-sc/ui?s=IDAI&p=W&b=5&g=0&id=p86431144783

The company’s (LWLG) innovative efforts were recognized at ECOC 2024, where Lightwave Logic received the Industry Award for Most Innovative Hybrid PIC/Optical Integration Platform. This accolade, bestowed by a committee of industry peers, marks the second consecutive year the company has won this aw

I’ve have been buying all along and plan to do so again at the open . The bases are loaded and I’m thinking fastball low and away that’s my wheelhouse .

MDAI..........................https://stockcharts.com/h-sc/ui?s=MDAI&p=W&b=5&g=0&id=p86431144783

German was just a "yes" man here. Nothing more than a puppet. There are some well seasoned crooks running this operation in the shadows,

$5,000 investments that are worth +$1 million:

Bitcoin: 9 yrs ago
Nvidia: 10 yrs ago
Tesla: 14 yrs ago
Netflix: 16 yrs ago
Apple: 20 yrs ago
Amazon: 22 yrs ago
Starbucks: 32 yrs ago
Microsoft: 33 yrs ago
Costco: 35 yrs ago

It’s looking more and more like nvda’s Cuda-Q has some serious patented competition . With Ionq’s over 600 patents issued or applied for worldwide, nvda has a large moat to try to get around. Not saying they can’t do it, but they now have a tuffer row to how.
https://x.com/DesFrontierTech/st

IBG.......................https://stockcharts.com/h-sc/ui?s=IBG&p=W&b=5&g=0&id=p86431144783

Get back in there baboon

CRWD
Crowdstrike price target raised to $400 from $310 at Susquehanna
Susquehanna analyst Shyam Patil raised the firm's price target on Crowdstrike to $400 from $310 and keeps a Positive rating on the shares. The firm said they reported a generally solid F3Q, though the outlook for

✅ Green is Good✅Set HIGH Sell Orders✅ Good Advice✅

ECON
U.S. MBA mortgage applications rose 6.3%
U.S. MBA mortgage applications rose 6.3% in the week ending November 22. It was the third consecutive week of improvement, after gains of 1.7% and 0.5% in the two weeks prior. Purchases jumped 12.4%, after rising 2.0% in the week ending

will it keep going?

CRM
Salesforce price target raised to $368 from $290 at Citi
Citi analyst Tyler Radke raised the firm's price target on Salesforce to $368 from $290 and keeps a Neutral rating on the shares. The firm says Agentforce has overtaken Salesforce's narrative with positive partner feedback

D
PagerDuty price target raised to $20 from $19 at Morgan Stanley
Morgan Stanley raised the firm's price target on PagerDuty to $20 from $19 and keeps an Equal Weight rating on the shares. ARR growth sustained at 10% for a fourth quarter in a row as revenue growth slightly improved

FDA Fast track green light will make this a 2Billion market cap in a blink of an eye

IFRX.........................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783

Besides being slow on the draw, while learning on the job, he's been getting things done. Am I out of patience? Most definitely...

Goes to figure some lessons have been learned on his end at this point, which should benefit all parties involved going forward. He could've bailed, but h

Can remove my post
I have no business here

Gl

FATE.........................https://stockcharts.com/h-sc/ui?s=FATE&p=W&b=5&g=0&id=p86431144783

Polariton
1h ago

Surface Plasmon Polaritons (SPPs) are electromagnetic waves that exist at the interface between metal and dielectric materials, enabling light manipulation on the nanoscale by overcoming the diffraction limit. 📖

Our improved Technology Ce

When companies split in ways that put them this far above the minimum requirement they usually do so when they expect much more downside and when they want to cater to the low float crowd instead of real investors in the bio space.

Well what do we think? Not ideal that’s for sure, but considering EU and UK approved, I’d like to think we are still going to be cash flow positive in the next 6 months, and what are the chances FDA approves on the fact that we still showed improvement in vision, and safety, over an unapproved versi